Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zen-Bio Inc.

Latest From Zen-Bio Inc.

Market Insight - Can ageing be slowed to prevent disease?

The idea of extending the human lifespan has long fascinated the public and challenged scientists. Funding for research into ageing processes, and the R&D of therapeutics to slow them, is increasing. Recent findings suggest that progress has been made, motivated in part by the rapid growth of elderly populations that might benefit from such advances. Furthermore, economists predict that many countries may face bankruptcy by 2050 (or earlier) because of rising healthcare expenditures associated with care of the elderly.

Metabolic Disorders Cardiovascular

Artecel Sciences Inc.

If recent studies are to be believed, America's obsession with diet and exercise has done little to trim the country's collective flab. While this is hardly good news on the health care front, one company is attempting to turn at least some of that fat into therapeutic muscle. In particular, Artecel Sciences Inc. is exploring ways in which cells harvested from fat tissue can be used in a variety of medical applications, including tissue repair and hematopoietic support for bone marrow transplantation.

See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Drug Discovery Tools